Braza, M. S., Klein, B., Fiol, G., & Rossi, J. (2011). γδ T-cell killing of primary follicular lymphoma cells is dramatically potentiated by GA101, a type II glycoengineered anti-CD20 monoclonal antibody. Ferrata Storti Foundation.
Citação norma ChicagoBraza, Mounia Sabrina, Bernard Klein, Geneviève Fiol, and Jean-François Rossi. γδ T-cell Killing of Primary Follicular Lymphoma Cells Is Dramatically Potentiated By GA101, a Type II Glycoengineered Anti-CD20 Monoclonal Antibody. Ferrata Storti Foundation, 2011.
Citação norma MLABraza, Mounia Sabrina, Bernard Klein, Geneviève Fiol, and Jean-François Rossi. γδ T-cell Killing of Primary Follicular Lymphoma Cells Is Dramatically Potentiated By GA101, a Type II Glycoengineered Anti-CD20 Monoclonal Antibody. Ferrata Storti Foundation, 2011.